Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in Proliferative Retinopathies
NCT00564148Phase 2Completed
- Sponsor
- Ophthalmological Association Edelweiss
- Start
- Jul 2007
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Retinal neovascularization, sponsored by Ophthalmological Association Edelweiss. Started Jul 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
Retinal neovascularization
Beyond the preview
Go deeper on NCT00564148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564148.